Increased Total Serum Immunoglobulin E in Children Developing Mycoplasma pneumoniae-related Extra-pulmonary Diseases
2 Department of Pediatrics, ASST Melegnano e Martesana, Vizzolo Predabissi, Milano, Italy
Mycoplasma pneumoniae has been recognized to be involved in several extra-pulmonary diseases, but the underlying immunologic mechanisms are still largely unknown. Recently, we observed a significant elevation of serum Immunoglobulin E (IgE) in a small group of these children. Here, we assessed total serum IgE levels in children affected with Mycoplasma pneumoniae-related extra-pulmonary diseases. We prospectively collected the data of 162 children admitted to the hospital (because of respiratory infections or extra-pulmonary diseases) who were evaluated for Mycoplasma pneumoniae serology and total serum IgE levels, concomitantly. Based upon clinical and serology aspects, 3 groups of children were identified: I) with non-mycoplasma respiratory disease; II) with mycoplasma-related respiratory diseases; III) with extra-pulmonary diseases related to concomitant/recent Mycoplasma pneumoniae infection. Interestingly, children with Mycoplasma pneumoniae-related extra-pulmonary diseases showed a significant elevation of total serum IgE. In particular, patients developing Mycoplasma pneumoniae-related extra-pulmonary diseases (group III) showed significantly higher level of IgE than both previous groups (p<0.001 vs. group I; p<0.01 vs. group II). In conclusion, hospitalized children diagnosed with Mycoplasma pneumoniae-related extra-pulmonary diseases resulted to have significantly increased serum IgE compared to children developing respiratory illnesses only.
1- Principi N, Esposito, S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections. Lancet Infect Dis. 2001; 1:334-344.
2- Timitilli A, Di Rocco M, Nattero G, Tacchella A, Giacchino R. Unusual manifestations of infections due to Mycoplasma pneumoniae in children. Infez Med. 2004; 2:113-117.
3- Sanchez-Vargas FM, Gomez-Duarte OG. Mycoplasma pneumoniae—an emerging extra-pulmonary pathogen. Clin Microbiol Infect. 2008; 14:105–115.
4- Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev. 2003; 83:417–432.
5- Yang J, Hooper WC, Phillips DJ, Yalkington DF. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun. 2002; 70:3649–365.
6- Yavlovich A, Tarchis M, Rotem S. Internalization and intracellular survival of Mycoplasma pneumoniae by nonphagocytic cells. FEMS Microbiol Lett. 2004; 233: 241–246.
7- Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother. 2010; 16:162–169.
8- Poddighe D, Marseglia GL. Is There any Relationship Between Extra-Pulmonary Manifestations of Mycoplasma Pneumoniae Infection and Atopy/Respiratory Allergy in Children? Pediatr Rep. 2016; 8:6395.
9- Capuano F, Grassi B, Pallavicini L, Greenberg Z, Lipson M. New Liaison® automated immunoassays for the detection of mycoplasma pneumoniae IgG and IgM antibodies in human serum/plasma specimens. 21st ECCMID / 27th ICC 2011, Milano (Italy), 7-10 May 2011.
10- Chaudhry RA, Varshney K, Malhotra P. Adhesion proteins of Mycoplasma pneumoniae. Front Biosci. 2007; 12:690–699.
11- Dallo SF, Baseman JB. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog. 2000; 29:301–309.
12- Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol. 2008; 3(6):635-648.
13- Hoek KL, Duffy LB, Cassell GH, Dai Y, Atkinson TP. A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells. Microb Pathog. 2005; 39:149–158.
16- Shao L, Cong Z, Li X, Zou H, Cao L, Guo Y. Changes in levels of IL-9, IL-17, IFN-γ, dendritic cell numbers and TLR expression in peripheral blood in asthmatic children with Mycoplasma pneumoniae infection. Int J Clin Exp Pathol 2015; 8(5):5263-5272.
17- Narita M. Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis. Front Microbiol. 2016; 7:doi10.3389/fmicb.2016.00023.
18- Sutherland ER, Brandorff JM, Martin RJ. Atypical bacterial pneumonia and asthma risk. J Asthma. 2004; 41(8):863–868.
19- Yan T. Role of anti-inflammatory cytokines in pathogenesis of pediatric mycoplasma pneumoniae pneumonia . J Biol Regul Homeost Agents. 2016; 30(2):541-545.
20- Hassan J, Irwin F, Dooley S, Connell J. Mycoplasma pneumoniae infection in a pediatric population: Analysis of soluble immune markers as risk factors for asthma. Human Immunology. 2008; 69:851-855.
23- Watanabe H, Uruma T, Nakamura H, Aoshiba K. Allergy Asthma Proc. 2014; 35(3):204-210.
24- Nagayama Y, Sakurai N, Kojima S, Funabashi S. Total and specific IgE resp[onses in the acute and recovery phases of respiratory infections in children. J Asthma. 1987; 24:159-166.
25- Koh YY, Park Y, Lee HJ, Kim CK. Bronchoalveolar lavage fluid from patients with mycoplasma pneumonia: implication of tendency toward increase immunoglobulin E production. Pediatrics. 2001; 107(3):39-46.
26- Smith-Norowitz TA, Silverberg JI, Kusonruksa M, et al. Asthmatic children have increased specific anti-Mycoplasma pneumoniae IgM but not IgG or IgE-values independent of history of respiratory tract infection. Pediatr Infect Dis J. 2013; 32(6), 599-603.
28- Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis. 1979; 139(6):681-687.
29- Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM. Infection with and Carriage of Mycoplasma pneumoniae in Children. Front Microbiol. 2016; 7, doi: 10.3389/fmicb.2016.00329.
31- Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z. The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children. PLoS ONE. 2016; 11(5):e0156465.
32- Pan Q, Gong L, Xiao H, Feng Y, Li L, Deng Z, Ye L, Zheng J, Dickerson CA, Ye L, An N, Yang C, Liu HF. Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus. Front Immunol. 2017 Mar 27;8:348.
33- Poddighe D, Marseglia GL. Commentary: Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus. Front Immunol. 2017 Jul 7;8:787.